Position in DHR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$887,065
-$161,423 QoQ
Shares Held
4,657
-15.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,137
of 2,092 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $6,906,466 across 9 Diagnostics & Research names. DHR ranks #2 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,230 | $2,622,112 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
4,657 | $887,065 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,353 | $716,535 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,357 | $578,740 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
1,092 | $574,872 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,640 | $459,200 | |
| 7 | NTRA |
Natera, Inc.
|
1,416 | $384,373 | |
| 8 | GRAL |
GRAIL, Inc.
|
5,182 | $353,775 |
All Filings in DHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $887,065 | 4,657 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,048,488 | 5,530 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,362,302 | 5,951 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,773,237 | 8,944 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,184,844 | 5,998 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,699,040 | 8,288 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||